These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36906857)

  • 81. Dicloxacillin-warfarin drug-drug interaction-A register-based study and in vitro investigations in 3D spheroid primary human hepatocytes.
    Järvinen E; Dalgård Dunvald AC; Ernst MT; Hammer HS; Pötz O; Pottegård A; Stage TB
    Br J Clin Pharmacol; 2023 Aug; 89(8):2614-2624. PubMed ID: 37021780
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes.
    Sahi J; Hamilton G; Sinz M; Barros S; Huang SM; Lesko LJ; LeCluyse EL
    Xenobiotica; 2000 Mar; 30(3):273-84. PubMed ID: 10752642
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation.
    Dvorak Z; Modriansky M; Pichard-Garcia L; Balaguer P; Vilarem MJ; Ulrichová J; Maurel P; Pascussi JM
    Mol Pharmacol; 2003 Jul; 64(1):160-9. PubMed ID: 12815172
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Investigation of CYP2B6, 3A4 and β-esterase interactions of Withania somnifera (L.) dunal in human liver microsomes and HepG2 cells.
    Kumar S; Bouic PJ; Rosenkranz B
    J Ethnopharmacol; 2021 Apr; 270():113766. PubMed ID: 33395575
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparative study of culture conditions for maintaining CYP3A4 and ATP-binding cassette transporters activity in primary cultured human hepatocytes.
    Takeba Y; Matsumoto N; Takenoshita-Nakaya S; Harimoto Y; Kumai T; Kinoshita Y; Nakano H; Ohtsubo T; Kobayashi S
    J Pharmacol Sci; 2011; 115(4):516-24. PubMed ID: 21436605
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Modulation of CYP450 Activities in Patients With Type 2 Diabetes.
    Gravel S; Chiasson JL; Turgeon J; Grangeon A; Michaud V
    Clin Pharmacol Ther; 2019 Dec; 106(6):1280-1289. PubMed ID: 31099895
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Spectroscopic observations of β-eudesmol binding to human cytochrome P450 isoforms 3A4 and 1A2, but not to isoforms 2C9, 2C19, and 2D6.
    Krenc D; Na-Bangchang K
    Xenobiotica; 2022 Feb; 52(2):199-208. PubMed ID: 35139770
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes.
    Raucy JL; Mueller L; Duan K; Allen SW; Strom S; Lasker JM
    J Pharmacol Exp Ther; 2002 Aug; 302(2):475-82. PubMed ID: 12130704
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of butylated hydroxytoluene, curcumin, propyl gallate and thiabendazole on cytochrome P450 forms in cultured human hepatocytes.
    Price RJ; Scott MP; Giddings AM; Walters DG; Stierum RH; Meredith C; Lake BG
    Xenobiotica; 2008 Jun; 38(6):574-86. PubMed ID: 18570159
    [TBL] [Abstract][Full Text] [Related]  

  • 90. An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes - application to establishing CYP2C8 inhibitor selectivity.
    Kahma H; Aurinsalo L; Neuvonen M; Katajamäki J; Paludetto MN; Viinamäki J; Launiainen T; Filppula AM; Tornio A; Niemi M; Backman JT
    Eur J Pharm Sci; 2021 Jul; 162():105810. PubMed ID: 33753217
    [TBL] [Abstract][Full Text] [Related]  

  • 91. In vitro evaluation of potential drug interactions mediated by cytochrome P450 and transporters for luseogliflozin, an SGLT2 inhibitor.
    Chino Y; Hasegawa M; Fukasawa Y; Mano Y; Bando K; Miyata A; Nakai Y; Endo H; Yamaguchi JI
    Xenobiotica; 2017 Apr; 47(4):314-323. PubMed ID: 27324291
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Assessment of a novel β2-adrenoceptor agonist, trantinterol, for interference with human liver cytochrome P450 enzymes activities.
    Jiang K; Li K; Qin F; Lu X; Li F
    Toxicol In Vitro; 2011 Aug; 25(5):1033-8. PubMed ID: 21466844
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.
    Yeh RF; Gaver VE; Patterson KB; Rezk NL; Baxter-Meheux F; Blake MJ; Eron JJ; Klein CE; Rublein JC; Kashuba AD
    J Acquir Immune Defic Syndr; 2006 May; 42(1):52-60. PubMed ID: 16639344
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cytochrome P450-mediated herb-drug interaction (HDI) of Polygonum multiflorum Thunb. based on pharmacokinetic studies and in vitro inhibition assays.
    Xing Y; Yu Q; Zhou L; Cai W; Zhang Y; Bi Y; Zhang Y; Fu Z; Han L
    Phytomedicine; 2023 Apr; 112():154710. PubMed ID: 36805481
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Janus kinase-dependent regulation of drug detoxifying protein expression by interleukin-22 in human hepatic cells.
    Le Vée M; Bruyère A; Jouan E; Fardel O
    Int Immunopharmacol; 2020 Jun; 83():106439. PubMed ID: 32234672
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Estimation of Fraction Metabolized by Cytochrome P450 Enzymes Using Long-Term Cocultured Human Hepatocytes.
    Klammers F; Goetschi A; Ekiciler A; Walter I; Parrott N; Fowler S; Umehara K
    Drug Metab Dispos; 2022 May; 50(5):566-575. PubMed ID: 35246464
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts.
    Donato MT; Lahoz A; Jiménez N; Pérez G; Serralta A; Mir J; Castell JV; Gómez-Lechón MJ
    Drug Metab Dispos; 2006 Sep; 34(9):1556-62. PubMed ID: 16763015
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of SHR0302 on the pharmacokinetics of CYP3A4, CYP2C8, CYP2C9 and CYP2C19 probe substrates in healthy volunteers: A cocktail analysis.
    Fu M; Luo L; Feng S; Lin H; Lu Z; Gu F; Fan Y; Wu B; Huang J; Shen K
    Br J Clin Pharmacol; 2023 Dec; 89(12):3659-3668. PubMed ID: 37464978
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: Implication for clinical drug-drug interactions.
    Zhang G; Ou R; Li F; Wu J; Zheng L; Tong Y; Liu Y; Liu Z; Lu L
    J Ethnopharmacol; 2016 Mar; 180():104-13. PubMed ID: 26805467
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effects of diosmetin on nine cytochrome P450 isoforms, UGTs and three drug transporters in vitro.
    Chen JJ; Zhang JX; Zhang XQ; Qi MJ; Shi MZ; Yang J; Zhang KZ; Guo C; Han YL
    Toxicol Appl Pharmacol; 2017 Nov; 334():1-7. PubMed ID: 28867436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.